The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Venetoclax (Ven) added to intensive chemo with cladribine, idarubicin, and AraC (CLIA) achieves high rates of durable complete remission with low rates of measurable residual disease (MRD) in pts with newly diagnosed acute myeloid leukemia (AML).
 
Tapan M. Kadia
Consulting or Advisory Role - Abbvie/Genentech; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Amgen; BiolineRx; Bristol-Myers Squibb; Celgene; Genentech/Abbvie; Incyte; Incyte; Jazz Pharmaceuticals; Pfizer; Pfizer; Sanofi
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Jazz Pharmaceuticals
Research Funding - Abbvie; Amphivena; Astex Pharmaceuticals; Bristol-Myers Squibb; celgene; H3 Biomedicine; Helsinn Therapeutics; Merck; Novartis; Onconova Therapeutics
 
Musa Yilmaz
No Relationships to Disclose
 
Courtney Denton Dinardo
Leadership - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; MedImmune; Syros Pharmaceuticals
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Marina Konopleva
Honoraria - Abbvie; Genentech; Roche
Consulting or Advisory Role - AbbVie; Genentech/Roche
Research Funding - Abbvie (Inst); Genentech (Inst); Roche (Inst)
 
Guillermo Montalban-Bravo
Research Funding - Jazz Pharmaceuticals (Inst)
 
Gautam Borthakur
Consulting or Advisory Role - Argenx; BiolineRx; BioTheryX; Nkarta; PTC Therapeutics; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Arvinas (Inst); AstraZeneca (Inst); BiolineRx (Inst); BioTheryX (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Scientific Affairs (Inst); Lilly (Inst); MedImmune (Inst); Mundipharma Research (Inst); Novartis (Inst); Oncoceutics (Inst); PTC Therapeutics (Inst); Ryvu Therapeutics (Inst); XBiotech (Inst)
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Nitin Jain
Research Funding - Abbvie (Inst)
 
Michael Andreeff
Stock and Other Ownership Interests - Aptose Biosciences; Eutropics; Oncoceutics; Oncolyze; Reata Pharmaceuticals; Senti Biosciences
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals
Research Funding - Amgen; AstraZeneca; Breast Cancer Research Foundation; CPRIT; Daiichi Sankyo; Karyopharm Therapeutics; NIH/NCI; Ono Pharmaceutical; United Therapeutics
Patents, Royalties, Other Intellectual Property - Patent with Reata
Travel, Accommodations, Expenses - Amgen; Aptose Biosciences; AstraZeneca; Oncoceutics
 
Nicholas James Short
No Relationships to Disclose
 
Ghayas C. Issa
No Relationships to Disclose
 
Maro Ohanian
No Relationships to Disclose
 
Prithviraj Bose
Honoraria - Blueprint Medicines; Celgene; CTI BioPharma Corp; Incyte; Kartos Therapeutics
Consulting or Advisory Role - Incyte
Speakers' Bureau - Incyte
Research Funding - Astellas Pharma (Inst); Blueprint Medicines (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Kartos Therapeutics (Inst); NS Pharma (Inst); Pfizer (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - Celgene; Incyte
 
Naval Guastad Daver
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Immunogen; Incyte; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Sa A Wang
No Relationships to Disclose
 
Rebecca Tidwell
Research Funding - Galera Therapeutics (Inst)
 
Zeev Estrov
No Relationships to Disclose
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Orsenix; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Orsenix; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Merck; Seagen; Selvita; Sunesis Pharmaceuticals; Xencor
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)